Moderna, Inc. announced that Corinne Le Goff, Pharm.D., MBA,will join Moderna as Chief Commercial Officer effective January 19, 2021. She will serve on Moderna’s Executive Committee and report to Chief Executive Officer Stéphane Bancel. Dr. Le Goff comes to Moderna from Amgen, where she served as SVP and President of the U.S. Business Organization. In this role, she was credited with the valuation and the successful commercial integration of Otezla®1, and for driving the growth strategy with increased contributions from Repatha®2 and Aimovig®3.